# clm_27270E64C661

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 421,514,000 United States dollar  
valid_from: 2008-12-31  
valid_to: 2009-06-30  
published: 2011-02-17  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_C2FCE96BEF20  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 421,514,000 United States dollar", as of 2008-12-31 (until 2009-06-30). Claim clm_27270E64C661, https://asof.is/claim/clm_27270E64C661, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-K FY2010, filed 2011-02-17  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677411000263/0001206774-11-000263-index.htm (primary, SEC EDGAR 10-K FY2010, published 2011-02-17)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 459,348,000 United States dollar | valid 2007-12-31 to 2008-12-31 | conf 0.95 | superseded | superseded_by [clm_27270E64C661](/claim/clm_27270E64C661.md) | [clm_E47A2EAF4706](/claim/clm_E47A2EAF4706.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.